Glenmark gets CDSCO Panel nod to manufacture,market Lobeglitazone, Metformin antidiabetic FDC Susmita Roy31 Oct 2022 12:30 PM GMTNew Delhi: Highlighting the clinical trial results that demonstrate the efficacy and safety of combination treatment of Lobeglitazone and Metformin in...
Covid-19 infection confers increased risk of diabetes after recovery MD Editorial Team23 March 2022 4:30 AM GMTDiabetes mellitus is a serious metabolic disorder that causes several other chronic diseases. The prevalence of diabetes in India has risen from 7.1%...
Bempedoic Acid and Ezetimibe Fixed Dose Combo effectively lowers LDL C in diabetics not on statins Lalhmangaihkimi23 Dec 2021 4:30 AM GMTBempedoic acid is the first class oral ATP-citrate lyase inhibitor. The combination of Bempedoic acid (BA) and ezetimibe fixed-dose combination (EZE...
DPP4 inhibitors reduce mortality risk in COVID-19 patients with diabetes: Study MD Editorial Team27 Oct 2021 3:30 AM GMTDiabetes is one of the most significant chronic diseases that increases the severity of COVID-19 and the associated risk of mortality in the pandemic....
Canagliflozin has no substantial effect on serum potassium levels: CANVAS program Dr. Shravani Dali18 Aug 2021 3:30 AM GMTCanagliflozin does not have a significant effect on serum potassium levels, suggests a Canagliflozin cardiovascular Assessment Study (CANVAS)...
